Acknowledgements |
|
xix | |
Introduction |
|
1 | (2) |
|
|
|
|
PART I Behavioural Sciences and Sociocultural Psychiatry |
|
|
3 | (40) |
|
1 Fundamentals of Psychology |
|
|
5 | (10) |
|
|
|
5 | (3) |
|
|
5 | (1) |
|
Thorndike's Law of Effect |
|
|
5 | (1) |
|
|
5 | (3) |
|
|
8 | (1) |
|
|
8 | (1) |
|
|
8 | (1) |
|
|
8 | (1) |
|
c) Social Learning Theory |
|
|
8 | (1) |
|
|
8 | (1) |
|
Bandura's Bobo Doll Experiment |
|
|
9 | (1) |
|
|
9 | (1) |
|
|
9 | (1) |
|
d) Perceptual Organisation |
|
|
9 | (1) |
|
Figure vs. Ground Differentiation |
|
|
9 | (1) |
|
Gestalt Principle of Perceptual Organisation |
|
|
9 | (1) |
|
Perception of Depth Distance and Motion |
|
|
9 | (1) |
|
e) Theories of Perception |
|
|
10 | (1) |
|
|
10 | (1) |
|
|
10 | (1) |
|
|
10 | (1) |
|
|
11 | (2) |
|
Non-Declarative (Implicit Memory) |
|
|
11 | (1) |
|
|
11 | (1) |
|
|
12 | (1) |
|
|
12 | (1) |
|
|
13 | (1) |
|
|
13 | (1) |
|
|
13 | (1) |
|
k) Brain Structures Involved in Memory |
|
|
13 | (2) |
|
2 Basic and Social Psychology |
|
|
15 | (17) |
|
|
|
15 | (3) |
|
Consider the Differing Concepts of Personality |
|
|
15 | (1) |
|
|
16 | (1) |
|
|
16 | (1) |
|
|
16 | (1) |
|
|
16 | (1) |
|
|
16 | (1) |
|
|
16 | (1) |
|
Personality Factor Approach |
|
|
16 | (1) |
|
|
17 | (1) |
|
The `BigFive' Personality Traits |
|
|
17 | (1) |
|
Measuring Personality Traits |
|
|
17 | (1) |
|
|
18 | (1) |
|
|
18 | (1) |
|
Cannon-Bard Theory (a. k a. Thalami Theory) |
|
|
18 | (1) |
|
Singer-Schachter Theory (a.k.a. Two-Factor Theory) |
|
|
19 | (1) |
|
|
19 | (1) |
|
|
19 | (1) |
|
Maslow's Hierarchy of Needs |
|
|
19 | (1) |
|
|
20 | (1) |
|
|
20 | (1) |
|
Osgood's Semantic Differential |
|
|
21 | (1) |
|
|
21 | (1) |
|
The National Adult Reading Test (NART) |
|
|
21 | (1) |
|
f) Cognitive Dissonance (Leon Festinger) |
|
|
21 | (1) |
|
|
22 | (1) |
|
|
22 | (1) |
|
|
23 | (2) |
|
|
25 | (1) |
|
Methods of Persuasive Communication |
|
|
25 | (1) |
|
|
25 | (1) |
|
|
26 | (3) |
|
Solomon Asch Conformity Experiment |
|
|
26 | (1) |
|
|
27 | (1) |
|
|
27 | (2) |
|
|
29 | (3) |
|
|
29 | (3) |
|
3 Sociocultural Psychiatry |
|
|
32 | (11) |
|
|
|
32 | (1) |
|
b Global Ethical Policies |
|
|
33 | (1) |
|
|
34 | (1) |
|
|
34 | (2) |
|
|
34 | (1) |
|
|
35 | (1) |
|
|
35 | (1) |
|
The Transtheoretical Model (TTM) |
|
|
35 | (1) |
|
|
36 | (1) |
|
f Theory of Expressed Emotion (EE) |
|
|
36 | (1) |
|
g Society and Mental Health |
|
|
37 | (1) |
|
h History of Major Publications in Psychiatry |
|
|
37 | (1) |
|
i Important Figures in Psychiatry |
|
|
38 | (1) |
|
j Immigration and Schizophrenia |
|
|
39 | (1) |
|
|
39 | (1) |
|
|
40 | (3) |
|
|
40 | (1) |
|
|
40 | (3) |
|
PART II Human Development |
|
|
43 | (18) |
|
4 Theories of Human Development |
|
|
45 | (16) |
|
|
a Piaget's Theory of Cognitive Development |
|
|
45 | (2) |
|
|
45 | (1) |
|
|
46 | (1) |
|
Concrete Operational Stage |
|
|
47 | (1) |
|
|
47 | (1) |
|
b The Zone of Proximal Development |
|
|
47 | (1) |
|
c Kohlberg's Theory of Moral Development |
|
|
47 | (1) |
|
d Freud's Stages of Psychosexual Development (1905) |
|
|
48 | (1) |
|
e Erikson's Stages of Psychosocial Development |
|
|
48 | (2) |
|
|
49 | (1) |
|
|
49 | (1) |
|
|
49 | (1) |
|
|
49 | (1) |
|
|
49 | (1) |
|
|
49 | (1) |
|
|
50 | (1) |
|
|
50 | (1) |
|
f) Mahler's `Separation-Individuation' Stages of Child Development (1968) |
|
|
50 | (1) |
|
g) Table of Relevant Developmental Stages |
|
|
50 | (1) |
|
|
50 | (1) |
|
|
51 | (1) |
|
j) Speech/Language Milestones |
|
|
51 | (1) |
|
|
52 | (1) |
|
|
52 | (1) |
|
m) Studies Related to Attachment |
|
|
53 | (1) |
|
|
54 | (1) |
|
o) Developmental Concepts |
|
|
55 | (1) |
|
|
55 | (1) |
|
|
55 | (1) |
|
r) Assessment of Intelligence |
|
|
56 | (5) |
|
PART III Basic Neurosciences |
|
|
61 | (58) |
|
|
63 | (15) |
|
|
|
63 | (1) |
|
|
63 | (1) |
|
|
63 | (2) |
|
|
65 | (4) |
|
Other Major Sulci Include |
|
|
66 | (3) |
|
e) Hemispheric Lateralization |
|
|
69 | (1) |
|
|
69 | (1) |
|
g) Subcortical Structures |
|
|
69 | (2) |
|
|
71 | (1) |
|
|
71 | (1) |
|
j) Brain Stem and Cranial Nerves |
|
|
72 | (1) |
|
|
72 | (1) |
|
|
72 | (1) |
|
|
73 | (1) |
|
m) Cerebrospinal Fluid (CSF) |
|
|
73 | (2) |
|
|
74 | (1) |
|
|
75 | (1) |
|
o) Blood-Brain Barrier (BBB) |
|
|
76 | (2) |
|
|
78 | (10) |
|
|
|
78 | (1) |
|
b) The Hypothalamic-Pituitary-Adrenal Axis (HPA) |
|
|
78 | (1) |
|
|
79 | (1) |
|
|
79 | (1) |
|
|
80 | (1) |
|
Post-Traumatic Stress Disorder |
|
|
80 | (1) |
|
f) Dexamethasone Suppression Tests (DSTs) |
|
|
80 | (1) |
|
|
81 | (1) |
|
h) Electroencephalograms (EEG) |
|
|
81 | (1) |
|
|
81 | (4) |
|
|
83 | (1) |
|
|
84 | (1) |
|
|
84 | (1) |
|
|
85 | (3) |
|
Intrinsic Sleep Disorders |
|
|
85 | (1) |
|
|
85 | (1) |
|
Periodic Limb Movement Disorder |
|
|
86 | (1) |
|
Restless Leg Syndrome (RLS) |
|
|
86 | (1) |
|
Rhythmic Movement Disorder |
|
|
86 | (1) |
|
|
86 | (1) |
|
|
86 | (1) |
|
Sleep Walking (Somnambulism) |
|
|
87 | (1) |
|
|
87 | (1) |
|
|
88 | (5) |
|
|
a) Classification of Receptors |
|
|
88 | (1) |
|
|
88 | (1) |
|
|
88 | (1) |
|
|
89 | (1) |
|
|
89 | (3) |
|
|
89 | (2) |
|
|
91 | (1) |
|
d) Monoamine Oxidase (MAO) |
|
|
92 | (1) |
|
|
92 | (1) |
|
|
93 | (15) |
|
|
|
93 | (1) |
|
|
93 | (1) |
|
|
94 | (1) |
|
|
94 | (1) |
|
|
95 | (1) |
|
|
96 | (1) |
|
|
96 | (3) |
|
|
96 | (1) |
|
|
97 | (1) |
|
|
97 | (1) |
|
|
98 | (1) |
|
|
99 | (1) |
|
h) Non-Mendelian Inheritance |
|
|
99 | (1) |
|
i) Techniques in Molecular Genetics |
|
|
100 | (1) |
|
|
100 | (1) |
|
|
101 | (1) |
|
l) Hardy-Weinberg Equilibrium |
|
|
101 | (1) |
|
|
101 | (1) |
|
|
101 | (1) |
|
|
102 | (1) |
|
n) Schizophrenia Genetics |
|
|
102 | (1) |
|
o) Affective Disorders Genetics |
|
|
103 | (1) |
|
|
103 | (1) |
|
|
103 | (1) |
|
|
103 | (1) |
|
q) Attention-Deficit/Hyperactivity Disorder (ADHD) Genetics |
|
|
104 | (1) |
|
r) Summary of Genetic Disorders |
|
|
104 | (4) |
|
9 Clinical Neuropathology |
|
|
108 | (6) |
|
|
a) Alzheimer's Disease (AD) |
|
|
108 | (1) |
|
Macroscopic Neuropathology |
|
|
108 | (1) |
|
Histological Changes/Microscopic |
|
|
108 | (1) |
|
b) Lewy Body Dementia (LBD) |
|
|
109 | (1) |
|
c) Frontotemporal Dementia (FTD) |
|
|
109 | (1) |
|
|
109 | (1) |
|
d) Creutzfeldt-Jakob Disease (CJD) |
|
|
110 | (1) |
|
|
111 | (1) |
|
|
112 | (1) |
|
g) Summary of Pathological Findings |
|
|
112 | (2) |
|
|
114 | (5) |
|
|
|
114 | (1) |
|
Anterior Frontal Lobe Lesions |
|
|
114 | (1) |
|
Medial Frontal Lobe (Broca's Area) Lesions |
|
|
114 | (1) |
|
Anterior Frontal Lobe Lesions |
|
|
114 | (1) |
|
|
114 | (1) |
|
|
114 | (2) |
|
Temporal Lobe Epilepsy (TLE) |
|
|
115 | (1) |
|
|
116 | (1) |
|
|
116 | (1) |
|
|
117 | (1) |
|
Language Production Model |
|
|
117 | (1) |
|
|
117 | (2) |
|
PART IV Clinical Psychopharmacology |
|
|
119 | (40) |
|
11 Mechanisms of Psychotropic Drugs |
|
|
121 | (6) |
|
|
a) Classification of Psychotropic Medications |
|
|
121 | (1) |
|
b) Typical Antipsychotics |
|
|
121 | (1) |
|
c) Atypical Antipsychotics |
|
|
122 | (1) |
|
|
122 | (1) |
|
e) Anxiolytics and Sedatives |
|
|
123 | (1) |
|
f) Antiepileptics and Mood Stabilisers |
|
|
124 | (1) |
|
|
124 | (1) |
|
|
124 | (1) |
|
i) Drugs Used in the Treatment of Substance Misuse |
|
|
124 | (1) |
|
|
125 | (2) |
|
12 Specifics of Prescribing |
|
|
127 | (17) |
|
|
|
127 | (1) |
|
b) Drugs With Psychiatric Side Effects |
|
|
127 | (2) |
|
c) Side Effects of Antidepressants |
|
|
129 | (1) |
|
d) Antidepressant Withdrawal |
|
|
129 | (1) |
|
e) Side Effects of Antipsychotics |
|
|
130 | (1) |
|
f) Metabolic Side Effects of Antipsychotics |
|
|
131 | (1) |
|
g) Antipsychotic Associated Hyperprolactinaemia |
|
|
131 | (1) |
|
|
132 | (1) |
|
i) Neuroleptic Malignant Syndrome and Serotonin Syndrome |
|
|
132 | (1) |
|
j) Allergies and Toxicity |
|
|
133 | (1) |
|
k) Specialist Drug Monitoring |
|
|
134 | (2) |
|
|
134 | (1) |
|
|
135 | (1) |
|
l) Prescribing in Special Groups |
|
|
136 | (1) |
|
m) Prescribing in Pregnancy and Breastfeeding |
|
|
137 | (2) |
|
n) Principles in Psychiatric Emergencies |
|
|
139 | (1) |
|
|
140 | (1) |
|
p) Electroconvulsive Therapy (ECT) |
|
|
141 | (1) |
|
q) Factors Affecting Medication Adherence |
|
|
142 | (1) |
|
|
142 | (2) |
|
|
144 | (11) |
|
|
|
144 | (1) |
|
|
144 | (1) |
|
|
145 | (2) |
|
|
147 | (3) |
|
|
150 | (5) |
|
14 Broader Aspects of Psychopharmacology |
|
|
155 | (4) |
|
|
|
155 | (1) |
|
b) Adverse Event Reporting |
|
|
156 | (3) |
|
PART V Classification and Assessment |
|
|
159 | (57) |
|
|
161 | (5) |
|
|
|
161 | (1) |
|
|
161 | (1) |
|
|
162 | (1) |
|
b) Changes From DSM-1V to DSM-5 |
|
|
162 | (1) |
|
c) Approaches to Classification |
|
|
163 | (3) |
|
|
163 | (1) |
|
|
164 | (1) |
|
Operational ised Approach |
|
|
164 | (1) |
|
|
164 | (2) |
|
16 History and Mental State Examination |
|
|
166 | (15) |
|
|
a) The Psychiatric History |
|
|
166 | (5) |
|
|
171 | (1) |
|
c) The Neurological Examination |
|
|
172 | (3) |
|
|
172 | (1) |
|
|
173 | (1) |
|
|
173 | (1) |
|
|
173 | (1) |
|
|
173 | (1) |
|
|
174 | (1) |
|
|
174 | (1) |
|
|
174 | (1) |
|
|
175 | (2) |
|
|
175 | (1) |
|
|
175 | (1) |
|
|
175 | (1) |
|
|
175 | (1) |
|
|
175 | (1) |
|
|
175 | (1) |
|
|
175 | (1) |
|
|
176 | (1) |
|
|
176 | (1) |
|
|
176 | (1) |
|
|
176 | (1) |
|
|
176 | (1) |
|
|
176 | (1) |
|
|
176 | (1) |
|
|
176 | (1) |
|
e) Specialist Dementia Scans |
|
|
177 | (1) |
|
|
177 | (1) |
|
|
178 | (1) |
|
h) Treatment With Comorbid HIV Infection |
|
|
178 | (1) |
|
i) Intelligence Quotient (IQ) |
|
|
178 | (1) |
|
|
179 | (2) |
|
|
179 | (1) |
|
|
179 | (2) |
|
|
181 | (17) |
|
|
|
181 | (1) |
|
b) Classifying Thought Form |
|
|
182 | (2) |
|
|
184 | (1) |
|
|
184 | (1) |
|
d) Classifying Thought Content |
|
|
185 | (4) |
|
|
185 | (1) |
|
|
186 | (3) |
|
Neuropsychology Theories of Delusions |
|
|
189 | (1) |
|
|
189 | (1) |
|
|
189 | (1) |
|
|
190 | (1) |
|
|
190 | (3) |
|
|
192 | (1) |
|
|
192 | (1) |
|
|
192 | (1) |
|
|
193 | (1) |
|
g) Disorders of Mood and Affect |
|
|
193 | (2) |
|
h) Disorders of Perception |
|
|
195 | (3) |
|
18 Diagnosis and ICD-10 Classification Codes |
|
|
198 | (18) |
|
|
|
198 | (1) |
|
b) F00--F09 Organic, Including Symptomatic, Mental Disorders |
|
|
198 | (1) |
|
F00 Dementia in Alzheimer's Disease |
|
|
199 | (1) |
|
|
199 | (1) |
|
F02 Dementia in Other Diseases Classified Elsewhere |
|
|
200 | (1) |
|
Cortical vs. Subcortical Dementia |
|
|
200 | (1) |
|
F05 Delirium, Not Induced by Alcohol and Other Psychoactive Substances |
|
|
201 | (1) |
|
c) F10--F19 Mental and Behavioural Disorders Due to Psychoactive Substance Use |
|
|
201 | (1) |
|
|
201 | (1) |
|
|
202 | (1) |
|
|
202 | (1) |
|
|
203 | (2) |
|
|
203 | (1) |
|
|
203 | (1) |
|
|
203 | (1) |
|
|
203 | (1) |
|
|
203 | (1) |
|
|
203 | (1) |
|
|
204 | (1) |
|
|
204 | (1) |
|
d) F20--F29 Schizophrenia, Schizotypal and Delusional Disorder |
|
|
205 | (1) |
|
|
205 | (1) |
|
Subtypes of Schizophrenia |
|
|
205 | (1) |
|
F20.0 Paranoid Schizophrenia |
|
|
205 | (1) |
|
Hebephrenic Schizophrenia |
|
|
205 | (1) |
|
|
205 | (1) |
|
F22 Persistent Delusional Disorder |
|
|
206 | (1) |
|
F23 Acute and Transient Psychotic Disorder |
|
|
206 | (2) |
|
|
207 | (1) |
|
e) F30--F39 Mood (Affective) Disorders |
|
|
208 | (1) |
|
|
208 | (1) |
|
|
208 | (1) |
|
F31 Bipolar Affective Disorder |
|
|
209 | (1) |
|
|
209 | (1) |
|
F32.0 Mild Depressive Episode |
|
|
210 | (1) |
|
F32.1 Moderate Depressive Episode |
|
|
210 | (1) |
|
F33 Recurrent Depressive Disorder |
|
|
210 | (1) |
|
|
210 | (1) |
|
|
210 | (1) |
|
f) F40--F49 Neurotic, Stress-Related and Somatoform Disorders |
|
|
211 | (1) |
|
F40 Phobic Anxiety Disorders |
|
|
211 | (1) |
|
|
211 | (1) |
|
|
211 | (1) |
|
|
211 | (1) |
|
F41 Other Anxiety Disorders |
|
|
211 | (1) |
|
|
211 | (1) |
|
F41.1 Generalised Anxiety Disorder |
|
|
211 | (1) |
|
F41.2 Mixed Anxiety and Depressive Disorder |
|
|
212 | (1) |
|
F42 Obsessive-Compulsive Disorder |
|
|
212 | (1) |
|
F43 Reaction to Severe Stress |
|
|
212 | (1) |
|
F43.1 Post-Traumatic Stress Disorder |
|
|
212 | (1) |
|
|
212 | (1) |
|
F45.0 Somatisation Disorder |
|
|
212 | (1) |
|
F45.2 Hypochondriacal Disorder |
|
|
212 | (1) |
|
F45.3 Somatoform Autonomic Dysfunction |
|
|
212 | (1) |
|
F45.4 Persistent Somatoform Pain Disorder |
|
|
213 | (1) |
|
g) F50--F59 Behavioural Syndromes Associated With Physiological Disturbances and Physical Factors |
|
|
213 | (1) |
|
|
213 | (1) |
|
F50.0 Anorexia Nervosa (AN) |
|
|
213 | (1) |
|
F50.1 Atypical Anorexia Nervosa (AN) |
|
|
213 | (1) |
|
F50.2 Bulimia Nervosa (BN) |
|
|
213 | (1) |
|
F50.3 Atypical Bulimia Nervosa |
|
|
213 | (1) |
|
h) F60--F69 Disorders of Adult Personality and Behaviour |
|
|
214 | |
Index |
|
216 | |